What GSK Layoffs Mean For Pharma In North Carolina

By Will Michaels,

Published December 4, 2014 at 12:12 PM EST

Pharmaceutical giant GlaxoSmithKline eliminated 900 jobs yesterday.

The cuts, which focus on employees at the Research Triangle Park location, are the latest in a series of restructuring decisions by the multi-billion dollar company. The moves suggest a changing business model for the pharmaceutical industry.

Reductions in the research and development sector mean more companies are shopping around for their next product rather than creating it themselves.

Host Frank Stasio talks with Triangle Business Journal reporter Jason deBruyn; BBC business reporter Russell Padmore; and Atul Nerkar, professor of strategy and entrepreneurship at UNC-Chapel Hill Kenan Flagler Business School, about the changing landscape of pharmaceuticals.

Tags

Will Michaels

Will Michaels is WUNC's Weekend Host and Reporter.

See stories by Will Michaels

Laura Lee

Laura Lee was the managing editor of The State of Things until mid February 2017. Born and raised in Monroe, North Carolina, Laura returned to the Old North state in 2013 after several years in Washington, DC. She received her B.A. in political science and international studies from UNC-Chapel Hill in 2002 and her J.D. from UNC-Chapel Hill School of Law in 2007.

See stories by Laura Lee

Frank Stasio

Longtime NPR correspondent Frank Stasio was named permanent host of The State of Things in June 2006. A native of Buffalo, Frank has been in radio since the age of 19. He began his public radio career at WOI in Ames, Iowa, where he was a magazine show anchor and the station's News Director.

See stories by Frank Stasio